REQUEST A DEMO
Total
USD $0.00
Search more companies

Orange Pharma EOOD (Ориндж Фарма ЕООД) (Bulgaria)

Main Activities: Pharmacies and Drug Stores
Full name: Orange Pharma EOOD Profile Updated: April 22, 2026
Buy our report for this company USD 29.95 Most recent financial data: 2024 Available in: English Download a sample report

Orange Pharma EOOD (Ориндж Фарма ЕООД) is based in Bulgaria, with the head office in Yambol. The company operates in the Pharmacies and Drug Stores industry. The company was established on September 14, 2026. Orange Pharma EOOD (Ориндж Фарма ЕООД) currently employs 12 (2024) people. In its most recent financial highlights, the company reported a net sales revenue increase of 30.29% in 2024. During that time, Orange Pharma EOOD (Ориндж Фарма ЕООД)’s total assets grew by 36.99%. The net profit margin of Orange Pharma EOOD (Ориндж Фарма ЕООД) increased by 2.25% in 2024.

Headquarters
Kukorevo
Yambol; Yambol; Postal Code: 8673

Contact Details: Purchase the Orange Pharma EOOD (Ориндж Фарма ЕООД) report to view the information.

Basic Information
Total Employees:
Purchase the Orange Pharma EOOD (Ориндж Фарма ЕООД) report to view the information.
Registered Capital:
Purchase the Orange Pharma EOOD (Ориндж Фарма ЕООД) report to view the information.
Financial Auditors:
Purchase the Orange Pharma EOOD (Ориндж Фарма ЕООД) report to view the information.
Incorporation Date:
September 14, 2026
Key Executives
Purchase this report to view the information.
Manager
Ownership Details
Purchase this report to view the information.
100%
Company Performance
Financial values in the chart are available after Orange Pharma EOOD (Ориндж Фарма ЕООД) report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency EUR. Absolute financial data is included in the purchased report.
Net sales revenue
30.29%
Total Operating Revenue
30.22%
Operating Profit
63.28%
EBITDA
57.96%
Net Profit/Loss for the Period
64.74%
Total Assets
36.99%
Total Equity
74.57%
Operating Profit Margin
2.45%
Net Profit Margin
2.25%
Return on Equity (ROE)
-5.02%
Debt / Equity
-6.56%
Quick Ratio
0.36%
Cash Ratio
0.25%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?